AstraZeneca buys into protein drugs for $200M+
January 7, 2022
WILMINGTON – Pharmaceutical giant AstraZeneca has signed two separate global development and commercialization agreements for drugs that treat a protein disease, signaling that the firm sees the patient segment as […]
chat_bubble0 Comment
visibility1388 Views
Premier Digital Partners
© 2024 Delaware Business Times
